Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity

Michael N. Teng, Ben H. Park, Hartmut K W Koeppen, Kevin J. Tracey, Brian M. Fendly, Hans Schreiber

Research output: Contribution to journalArticle

Abstract

The relationship between detrimental (cachectic) and beneficial (antitumor) effects of tumor necrosis factor (INF) was studied in mice bearing murine tumors transfected to secrete human TNF. In vitro, the TNF-producing transfectants were resistant to the secreted TNF and grew at rates similar to those of untransfected cells or transfected cells that did not secrete TNF. However, tumors formed by the TNF-secreting cells in vivo remained much smaller than the nonsecreting (transfected and untransfected) tumors. This inhibition of tumor growth required only relatively low serum levels of TNF, persisted for many weeks, and was independent of T cells since it occurred in nude mice. Growth of the TNF-secreting tumors increased dramatically after treatment with anti-human TNF antibody, indicating that extracellular TNF secreted by the tumor cells was necessary for the tumor inhibition. Severe weight loss characteristic of cachexia only occurred in animals with very high serum TNF levels (250 pg/ml) and could be prevented or reversed by anti-TNF antibody treatment. These data are consistent with the existence of a therapeutic window in which persistent exposure to human TNF can lead to prolonged inhibition of tumor growth in the absence of T-cell immunity or severe weight loss and without development of resistant tumor variants.

Original languageEnglish (US)
Pages (from-to)3535-3539
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume88
Issue number9
StatePublished - 1991
Externally publishedYes

Fingerprint

Cachexia
Immunity
Tumor Necrosis Factor-alpha
T-Lymphocytes
Growth
Neoplasms
Weight Loss
Serum
Nude Mice
Anti-Idiotypic Antibodies
Antibodies

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. / Teng, Michael N.; Park, Ben H.; Koeppen, Hartmut K W; Tracey, Kevin J.; Fendly, Brian M.; Schreiber, Hans.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, No. 9, 1991, p. 3535-3539.

Research output: Contribution to journalArticle

Teng, Michael N. ; Park, Ben H. ; Koeppen, Hartmut K W ; Tracey, Kevin J. ; Fendly, Brian M. ; Schreiber, Hans. / Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. In: Proceedings of the National Academy of Sciences of the United States of America. 1991 ; Vol. 88, No. 9. pp. 3535-3539.
@article{5ab83206d761408a8de69c00448dfa51,
title = "Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity",
abstract = "The relationship between detrimental (cachectic) and beneficial (antitumor) effects of tumor necrosis factor (INF) was studied in mice bearing murine tumors transfected to secrete human TNF. In vitro, the TNF-producing transfectants were resistant to the secreted TNF and grew at rates similar to those of untransfected cells or transfected cells that did not secrete TNF. However, tumors formed by the TNF-secreting cells in vivo remained much smaller than the nonsecreting (transfected and untransfected) tumors. This inhibition of tumor growth required only relatively low serum levels of TNF, persisted for many weeks, and was independent of T cells since it occurred in nude mice. Growth of the TNF-secreting tumors increased dramatically after treatment with anti-human TNF antibody, indicating that extracellular TNF secreted by the tumor cells was necessary for the tumor inhibition. Severe weight loss characteristic of cachexia only occurred in animals with very high serum TNF levels (250 pg/ml) and could be prevented or reversed by anti-TNF antibody treatment. These data are consistent with the existence of a therapeutic window in which persistent exposure to human TNF can lead to prolonged inhibition of tumor growth in the absence of T-cell immunity or severe weight loss and without development of resistant tumor variants.",
author = "Teng, {Michael N.} and Park, {Ben H.} and Koeppen, {Hartmut K W} and Tracey, {Kevin J.} and Fendly, {Brian M.} and Hans Schreiber",
year = "1991",
language = "English (US)",
volume = "88",
pages = "3535--3539",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "9",

}

TY - JOUR

T1 - Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity

AU - Teng, Michael N.

AU - Park, Ben H.

AU - Koeppen, Hartmut K W

AU - Tracey, Kevin J.

AU - Fendly, Brian M.

AU - Schreiber, Hans

PY - 1991

Y1 - 1991

N2 - The relationship between detrimental (cachectic) and beneficial (antitumor) effects of tumor necrosis factor (INF) was studied in mice bearing murine tumors transfected to secrete human TNF. In vitro, the TNF-producing transfectants were resistant to the secreted TNF and grew at rates similar to those of untransfected cells or transfected cells that did not secrete TNF. However, tumors formed by the TNF-secreting cells in vivo remained much smaller than the nonsecreting (transfected and untransfected) tumors. This inhibition of tumor growth required only relatively low serum levels of TNF, persisted for many weeks, and was independent of T cells since it occurred in nude mice. Growth of the TNF-secreting tumors increased dramatically after treatment with anti-human TNF antibody, indicating that extracellular TNF secreted by the tumor cells was necessary for the tumor inhibition. Severe weight loss characteristic of cachexia only occurred in animals with very high serum TNF levels (250 pg/ml) and could be prevented or reversed by anti-TNF antibody treatment. These data are consistent with the existence of a therapeutic window in which persistent exposure to human TNF can lead to prolonged inhibition of tumor growth in the absence of T-cell immunity or severe weight loss and without development of resistant tumor variants.

AB - The relationship between detrimental (cachectic) and beneficial (antitumor) effects of tumor necrosis factor (INF) was studied in mice bearing murine tumors transfected to secrete human TNF. In vitro, the TNF-producing transfectants were resistant to the secreted TNF and grew at rates similar to those of untransfected cells or transfected cells that did not secrete TNF. However, tumors formed by the TNF-secreting cells in vivo remained much smaller than the nonsecreting (transfected and untransfected) tumors. This inhibition of tumor growth required only relatively low serum levels of TNF, persisted for many weeks, and was independent of T cells since it occurred in nude mice. Growth of the TNF-secreting tumors increased dramatically after treatment with anti-human TNF antibody, indicating that extracellular TNF secreted by the tumor cells was necessary for the tumor inhibition. Severe weight loss characteristic of cachexia only occurred in animals with very high serum TNF levels (250 pg/ml) and could be prevented or reversed by anti-TNF antibody treatment. These data are consistent with the existence of a therapeutic window in which persistent exposure to human TNF can lead to prolonged inhibition of tumor growth in the absence of T-cell immunity or severe weight loss and without development of resistant tumor variants.

UR - http://www.scopus.com/inward/record.url?scp=0025875209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025875209&partnerID=8YFLogxK

M3 - Article

C2 - 2023898

AN - SCOPUS:0025875209

VL - 88

SP - 3535

EP - 3539

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 9

ER -